-
1
-
-
0346847742
-
Is breast cancer survival improving?
-
10.1002/cncr.11859, 14692023
-
Giordano SH, Buzdar AU, Smith TL, Kau SW, Yang Y, Hortobagyi GN. Is breast cancer survival improving?. Cancer 2004, 100(1):44-52. 10.1002/cncr.11859, 14692023.
-
(2004)
Cancer
, vol.100
, Issue.1
, pp. 44-52
-
-
Giordano, S.H.1
Buzdar, A.U.2
Smith, T.L.3
Kau, S.W.4
Yang, Y.5
Hortobagyi, G.N.6
-
2
-
-
19944422061
-
A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer
-
10.1056/NEJMoa041588, 15591335
-
Paik S, Shak S, Tang G, Kim C, Baker J, Cronin M, Baehner FL, Walker MG, Watson D, Park T, Hiller W, Fisher ER, Wickerham DL, Bryant J, Wolmark N. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med 2004, 351(27):2817-2826. 10.1056/NEJMoa041588, 15591335.
-
(2004)
N Engl J Med
, vol.351
, Issue.27
, pp. 2817-2826
-
-
Paik, S.1
Shak, S.2
Tang, G.3
Kim, C.4
Baker, J.5
Cronin, M.6
Baehner, F.L.7
Walker, M.G.8
Watson, D.9
Park, T.10
Hiller, W.11
Fisher, E.R.12
Wickerham, D.L.13
Bryant, J.14
Wolmark, N.15
-
3
-
-
70350608454
-
Breast cancer in developing countries
-
doi:10.1016/S0140-6736(09)61930-9, 10.1016/S0140-6736(09)61930-9, 19897110
-
Breast cancer in developing countries. Lancet 2009, 374(9701):1567. doi:10.1016/S0140-6736(09)61930-9, 10.1016/S0140-6736(09)61930-9, 19897110.
-
(2009)
Lancet
, vol.374
, Issue.9701
, pp. 1567
-
-
-
4
-
-
84870805026
-
Hiding in plain view: the potential for commonly used drugs to reduce breast cancer mortality
-
10.1186/bcr3336, 4053125, 23227958
-
Holmes MD, Chen WY. Hiding in plain view: the potential for commonly used drugs to reduce breast cancer mortality. Breast Cancer Res 2012, 14(2):216. 10.1186/bcr3336, 4053125, 23227958.
-
(2012)
Breast Cancer Res
, vol.14
, Issue.2
, pp. 216
-
-
Holmes, M.D.1
Chen, W.Y.2
-
6
-
-
34547504685
-
The new Swedish Prescribed Drug Register-opportunities for pharmacoepidemiological research and experience from the first six months
-
10.1002/pds.1294, 16897791
-
Wettermark B, Hammar N, Fored CM, Leimanis A, Otterblad Olausson P, Bergman U, Persson I, Sundstrom A, Westerholm B, Rosen M. The new Swedish Prescribed Drug Register-opportunities for pharmacoepidemiological research and experience from the first six months. Pharmacoepidemiol Drug Saf 2007, 16(7):726-735. 10.1002/pds.1294, 16897791.
-
(2007)
Pharmacoepidemiol Drug Saf
, vol.16
, Issue.7
, pp. 726-735
-
-
Wettermark, B.1
Hammar, N.2
Fored, C.M.3
Leimanis, A.4
Otterblad Olausson, P.5
Bergman, U.6
Persson, I.7
Sundstrom, A.8
Westerholm, B.9
Rosen, M.10
-
7
-
-
0030005551
-
The risk of stomach cancer in patients with gastric or duodenal ulcer disease
-
10.1056/NEJM199607253350404, 8657240
-
Hansson LE, Nyren O, Hsing AW, Bergstrom R, Josefsson S, Chow WH, Fraumeni JF, Adami HO. The risk of stomach cancer in patients with gastric or duodenal ulcer disease. N Engl J Med 1996, 335(4):242-249. 10.1056/NEJM199607253350404, 8657240.
-
(1996)
N Engl J Med
, vol.335
, Issue.4
, pp. 242-249
-
-
Hansson, L.E.1
Nyren, O.2
Hsing, A.W.3
Bergstrom, R.4
Josefsson, S.5
Chow, W.H.6
Fraumeni, J.F.7
Adami, H.O.8
-
8
-
-
84904741254
-
Lesser known facts about nested case-control designs
-
Kim RS. Lesser known facts about nested case-control designs. J Transl Med Epidemiol 2013, 1(1):1007.
-
(2013)
J Transl Med Epidemiol
, vol.1
, Issue.1
, pp. 1007
-
-
Kim, R.S.1
-
9
-
-
34250022123
-
NSAIDs and breast cancer recurrence in a prospective cohort study
-
10.1007/s10552-007-9003-y, 3461348, 17404892
-
Kwan ML, Habel LA, Slattery ML, Caan B. NSAIDs and breast cancer recurrence in a prospective cohort study. Cancer Causes Control 2007, 18(6):613-620. 10.1007/s10552-007-9003-y, 3461348, 17404892.
-
(2007)
Cancer Causes Control
, vol.18
, Issue.6
, pp. 613-620
-
-
Kwan, M.L.1
Habel, L.A.2
Slattery, M.L.3
Caan, B.4
-
10
-
-
33846317387
-
NSAID use and survival after breast cancer diagnosis in post-menopausal women
-
10.1007/s10549-006-9277-x, 16823508
-
Blair CK, Sweeney C, Anderson KE, Folsom AR. NSAID use and survival after breast cancer diagnosis in post-menopausal women. Breast Cancer Res Treat 2007, 101(2):191-197. 10.1007/s10549-006-9277-x, 16823508.
-
(2007)
Breast Cancer Res Treat
, vol.101
, Issue.2
, pp. 191-197
-
-
Blair, C.K.1
Sweeney, C.2
Anderson, K.E.3
Folsom, A.R.4
-
11
-
-
77951921896
-
Aspirin intake and survival after breast cancer
-
doi:10.1200/JCO.2009.22.7918. Epub 2010 Feb 16. PMID: 20159825, 10.1200/JCO.2009.22.7918, 2849768, 20159825
-
Holmes MD, Chen WY, Li L, Hertzmark E, Spiegelman D, Hankinson SE. Aspirin intake and survival after breast cancer. J Clin Oncol 2010, 28(9):1467-1472. doi:10.1200/JCO.2009.22.7918. Epub 2010 Feb 16. PMID: 20159825, 10.1200/JCO.2009.22.7918, 2849768, 20159825.
-
(2010)
J Clin Oncol
, vol.28
, Issue.9
, pp. 1467-1472
-
-
Holmes, M.D.1
Chen, W.Y.2
Li, L.3
Hertzmark, E.4
Spiegelman, D.5
Hankinson, S.E.6
-
12
-
-
84863399038
-
Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials
-
10.1016/S0140-6736(12)60209-8, 22440947
-
Rothwell PM, Wilson M, Price JF, Belch JF, Meade TW, Mehta Z. Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials. Lancet 2012, 379(9826):1591-1601. 10.1016/S0140-6736(12)60209-8, 22440947.
-
(2012)
Lancet
, vol.379
, Issue.9826
, pp. 1591-1601
-
-
Rothwell, P.M.1
Wilson, M.2
Price, J.F.3
Belch, J.F.4
Meade, T.W.5
Mehta, Z.6
-
13
-
-
84860467522
-
Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials
-
doi:10.1016/S1470-2045(12)70112-2. Epub 2012 Mar 21. Review. PMID: 22440112., 10.1016/S1470-2045(12)70112-2, 22440112
-
Algra AM, Rothwell PM. Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials. Lancet Oncol 2012, 13(5):518-527. doi:10.1016/S1470-2045(12)70112-2. Epub 2012 Mar 21. Review. PMID: 22440112., 10.1016/S1470-2045(12)70112-2, 22440112.
-
(2012)
Lancet Oncol
, vol.13
, Issue.5
, pp. 518-527
-
-
Algra, A.M.1
Rothwell, P.M.2
-
14
-
-
84904759045
-
Pharmaceuticals - Statistics for 2009
-
Pharmaceuticals - Statistics for 2009. http://www.socialstyrelsen.se/Lists/Artikelkatalog/Attachments/18278/2011-3-30.pdf.
-
-
-
-
15
-
-
84862913805
-
Use of nonsteroidal anti-inflammatory drugs and survival following breast cancer diagnosis
-
10.1158/1055-9965.EPI-11-1012, 3253909, 22068285
-
Li Y, Brasky TM, Nie J, Ambrosone CB, McCann SE, Shields PG, Trevisan M, Edge SB, Freudenheim JL. Use of nonsteroidal anti-inflammatory drugs and survival following breast cancer diagnosis. Cancer Epidemiol Biomarkers Prev 2012, 21(1):239-242. 10.1158/1055-9965.EPI-11-1012, 3253909, 22068285.
-
(2012)
Cancer Epidemiol Biomarkers Prev
, vol.21
, Issue.1
, pp. 239-242
-
-
Li, Y.1
Brasky, T.M.2
Nie, J.3
Ambrosone, C.B.4
McCann, S.E.5
Shields, P.G.6
Trevisan, M.7
Edge, S.B.8
Freudenheim, J.L.9
-
16
-
-
84862905617
-
Hazard of recurrence among women after primary breast cancer treatment-a 10-year follow-up using data from SEER-Medicare
-
10.1158/1055-9965.EPI-11-1089, 22426147
-
Cheng L, Swartz MD, Zhao H, Kapadia AS, Lai D, Rowan PJ, Buchholz TA, Giordano SH. Hazard of recurrence among women after primary breast cancer treatment-a 10-year follow-up using data from SEER-Medicare. Cancer Epidemiol Biomarkers Prev 2012, 21(5):800-809. 10.1158/1055-9965.EPI-11-1089, 22426147.
-
(2012)
Cancer Epidemiol Biomarkers Prev
, vol.21
, Issue.5
, pp. 800-809
-
-
Cheng, L.1
Swartz, M.D.2
Zhao, H.3
Kapadia, A.S.4
Lai, D.5
Rowan, P.J.6
Buchholz, T.A.7
Giordano, S.H.8
|